Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64976 - 65000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	DLD	1738	upregulated	resveratrol results in increased expression of DLD mRNA	7q31.1	A23855
Resveratrol	Investigational	DMKN	93099	upregulated	resveratrol results in increased expression of DMKN mRNA	19q13.12	A23852
Resveratrol	Investigational	DNA2	1763	downregulated	resveratrol results in decreased expression of DNA2 mRNA	10q21.3	A23857
Resveratrol	Investigational	DNMT1	1786	downregulated	resveratrol results in decreased expression of DNMT1 mRNA	19p13.2	A21623 A21826 A23851
Resveratrol	Investigational	DNMT3A	1788	downregulated	resveratrol results in decreased expression of DNMT3A mRNA	2p23.3	A21826
Resveratrol	Investigational	DNMT3B	1789	downregulated	resveratrol results in decreased expression of DNMT3B mRNA	20q11.21	A21826 A23926
Resveratrol	Investigational	DNMT3B	1789	upregulated	resveratrol results in increased expression of DNMT3B mRNA	20q11.21	A23851
Resveratrol	Investigational	DOK4	55715	upregulated	resveratrol results in increased expression of DOK4 mRNA	16q21	A22289
Resveratrol	Investigational	DONSON	29980	upregulated	resveratrol results in increased expression of DONSON mRNA	21q22.11	A21103
Resveratrol	Investigational	DRAM1	55332	upregulated	resveratrol results in increased expression of DRAM1 mRNA	12q23.2	A23856
Resveratrol	Investigational	DUSP10	11221	upregulated	resveratrol results in increased expression of DUSP10 mRNA	1q41	A21827
Resveratrol	Investigational	DUSP8	1850	upregulated	resveratrol results in increased expression of DUSP8 mRNA	11p15.5	A23859
Resveratrol	Investigational	DYNLL1	8655	upregulated	resveratrol results in increased expression of DYNLL1 mRNA	12q24.31	A20482
Resveratrol	Investigational	DYRK1A	1859	downregulated	resveratrol results in decreased expression of DYRK1A mRNA	21q22.13	A23847
Resveratrol	Investigational	E4F1	1877	upregulated	resveratrol results in increased expression of E4F1 mRNA	16p13.3	A22498
Resveratrol	Investigational	ECE1	1889	downregulated	resveratrol results in decreased expression of ECE1 mRNA	1p36.12	A23927
Resveratrol	Investigational	EDN1	1906	downregulated	resveratrol results in decreased expression of EDN1 mRNA	6p24.1	A22961 A22962 A22523 A23876
Resveratrol	Investigational	EDN2	1907	upregulated	resveratrol results in increased expression of EDN2 mRNA	1p34.2	A23852
Resveratrol	Investigational	EDRF1	26098	upregulated	resveratrol results in increased expression of EDRF1 mRNA	10q26.2	A23908
Resveratrol	Investigational	EGFR	1956	downregulated	resveratrol results in decreased expression of EGFR mRNA	7p11.2	A23854
Resveratrol	Investigational	EGR1	1958	upregulated	resveratrol results in increased expression of EGR1 mRNA	5q31.2	A23928 A23901 A23929 A23876 A23861 A23777
Resveratrol	Investigational	EI24	9538	upregulated	resveratrol results in increased expression of EI24 mRNA	11q24.2	A23847 A23867
Resveratrol	Investigational	EIF2B4	8890	upregulated	resveratrol results in increased expression of EIF2B4 mRNA	2p23.3	A22289
Resveratrol	Investigational	EIF4A2	1974	downregulated	resveratrol results in decreased expression of EIF4A2 mRNA	3q27.3	A23857
Resveratrol	Investigational	EIF5	1983	downregulated	resveratrol results in decreased expression of EIF5 mRNA	14q32.32	A21103

Displaying entries 64976 - 65000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability